Vecamyl (mecamylamine hydrochloride tablets) — Medica

Initial criteria

• Patient has tried four antihypertensive therapies, each from different pharmacologic classes (e.g., diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers [as single-entity or as combination products])
• For each of these agents, patient meets ONE of the following (i or ii): i. Patient has had inadequate efficacy; OR ii. Patient has experienced adverse event(s) severe enough to warrant discontinuation of this agent, according to the prescriber

Approval duration

1 year